| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 5, 2026 | ±3.1% | +2.4% | over-priced |
| November 6, 2025 | ±2.2% | -2.1% | over-priced |
| August 8, 2025 | ±2.4% | +2.0% | over-priced |
| May 9, 2025 | ±2.7% | +5.4% | under-priced |
| November 8, 2024 | ±2.7% | -3.5% | under-priced |
| August 9, 2024 | ±4.3% | +3.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.07 | $2.0B | $13M |
| Q4 FY2025 | $0.35 | $2.0B | $63M |
| Q3 FY2025 | $7.22 | $2.1B | $1.3B |
| Q2 FY2025 | $0.51 | $2.2B | $90M |
Solventum Corporation (SOLV) reports in 96 days, with the next report estimated for September 17, 2026. Across the last 6 reports, options priced an average ±2.9% earnings move while the stock actually moved 3.1% on average — the market has been roughly fair on SOLV's earnings risk. Fundamentals into the print: EPS down 91.0% year-over-year, revenue down 3.0%. QuantLogix's live 5-factor engine currently reads SOLV as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →